Download PDF
Horm Metab Res 2004; 36(6): 376-380
DOI: 10.1055/s-2004-814583
Review
© Georg Thieme Verlag Stuttgart · New York

Mechanisms of Obesity-related Hypertension

V.  Lamounier-Zepter 1, 2 , S.  R.  Bornstein 1 , M.  Ehrhart-Bornstein 2
  • 1Department of Endocrinology, University Medical Center, Heinrich Heine University, Düsseldorf, Germany
  • 2German Diabetes Center, Düsseldorf, Germany
Further Information

Publication History

Received 9 February 2004

Accepted after Revision 19 February 2004

Publication Date:
07 July 2004 (online)

Also available at
    Permissions and Reprints

Abstract

Obesity has become an epidemic problem in western societies, contributing to metabolic diseases, hypertension and cardiovascular disease. Although the importance of obesity as a cause of hypertension is well established, the molecular basis of the relationship between obesity and increased blood pressure remains poorly understood. This brief review examines the association between obesity and hypertension along with the mechanisms proposed to explain this association, while presenting evidence of a direct causal effect of adipose tissue in the development of hypertension through the involvement of the adrenal cortex.

Key words

Overweight - Adipose tissue - Adrenal - Aldosterone

References

  • 1 World Health Organization. Obesity - preventing and managing the global epidemic: report of a WHO consultation on obesity. Geneva; WHO 1998
    Google Scholar
  • 2 Flegal K M, Carroll M D, Ogden C L, Johnson C L. Prevalence and trends in obesity among US adults, 1999 - 2000.  JAMA. 2002;  288 1723-1727
    CrossrefPubMedGoogle Scholar
  • 3 World Health Organization. MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35 - 64 years.  World Health Stat Quart. 1988;  41 115-140
    PubMedGoogle Scholar
  • 4 Kopelman P G. Obesity as a medical problem.  Nature. 2000;  404 635-643
    CrossrefPubMedGoogle Scholar
  • 5 Calle E E, Rodriguez C, Walker-Thurmond K, Thun M J. Overweight, obesity, and mortality from cancer in a prospectively studies cohort of U.S. adults.  N Engl J Med. 2003;  348 1625-1638
    CrossrefPubMedGoogle Scholar
  • 6 Goodfriend T L, Calhoun D A. Resistant hypertension, obesity, sleep apnea, and aldosterone. Theory and therapy.  Hypertension. 2004;  43 1-7
    PubMedGoogle Scholar
  • 7 Cooper R S, Rotimi C N, Ward R. The puzzle of hypertension in African-Americans.  Sci Am. 1999;  280 56-63
    PubMedGoogle Scholar
  • 8 Jones D W, Kim J S, Andrew M E, Kim S J, Hong Y P. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey.  J Hypertens. 1994;  12 1433-1437
    PubMedGoogle Scholar
  • 9 Doll S, Paccaud F, Bovet P. et al . Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int.  J Obes Relat Metab Disord. 2002;  26 48-57
    PubMedGoogle Scholar
  • 10 Garrison R J, Kannel W B, Stokes J, Castelli W P. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study.  Prev Med. 1987;  16 235-251
    CrossrefPubMedGoogle Scholar
  • 11 Miller E R, Erlinger T P, Young D R, Jehn M, Charleston J, Rhodes D, Wasan S K, Appel L J. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).  Hypertension. 2002;  40 612-618
    CrossrefPubMedGoogle Scholar
  • 12 He J, Whelton P K, Appel J L, Chalerston J, Klag M J. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.  Hypertension. 2000;  35 544-549
    PubMedGoogle Scholar
  • 13 Hall J E, Jones D W, Kuo J J, da Silva A, Tallam L S, Liu J. Impact of the obesity epidemic on hypertension and renal disease.  Curr Hypertens Rep. 2003;  5 386-392
    PubMedGoogle Scholar
  • 14 Tuck M L. Obesity, the sympathetic nervous system, and essential hypertension.  Hypertension. 1992;  19 167-177
    PubMedGoogle Scholar
  • 15 Masuo K. Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.  Curr Hypertens Rep. 2002;  4 112-118
    PubMedGoogle Scholar
  • 16 Engeli S, Sharma A M. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension.  J Mol Med. 2001;  79 21-29
    CrossrefPubMedGoogle Scholar
  • 17 Hong G, Lockhart A, Davis B, Rahmoune H, Baker S, Ye L, Thompson P, Shou Y, O’Shaughnessy K, Ronco P, Brown J. PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells.  FASEB J. 2003;  17 1966-1968
    PubMedGoogle Scholar
  • 18 Troisi R J, Weiss S T, Parker D R, Sparrow D, Young J B, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity.  Hypertension. 1991;  17 669-677
    PubMedGoogle Scholar
  • 19 Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects.  Circulation. 1994;  89 2634-2640
    PubMedGoogle Scholar
  • 20 Grassi U, Seravalle G, Cattaneo B M, Bolla G B, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects.  Hypertension. 1995;  25 560-563
    PubMedGoogle Scholar
  • 21 Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.  Circulation. 1997;  96 3423-3429
    CrossrefPubMedGoogle Scholar
  • 22 Rumantir M S, Vaz M, Jennings G L, Collier G, Kaye D M, Seals D R, Wiesner G H, Brunner-La R occa, HP , Esler M D. Neural mechanisms in human obesity-related hypertension.  J Hypertens. 1999;  17 1125-1133
    CrossrefPubMedGoogle Scholar
  • 23 Kassab S, Kato T, Wilkins F C, Chen R, Hall J E, Granger J P. Renal denervation attenuates the sodium retention and hypertension associated with obesity.  Hypertension. 1995;  25 893-897
    PubMedGoogle Scholar
  • 24 Jequier E. Leptin signaling, adiposity, and energy balance.  Ann NY Acad Sci. 2002;  967 379-388
    PubMedGoogle Scholar
  • 25 Torpy D J, Bornstein S R, Chrousos G P. Leptin and interleukin-6 in sepsis.  Horm Metab Res. 1998;  30 726-729
    PubMedGoogle Scholar
  • 26 Bornstein S R, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum W A. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Leptin inhibits cortisol release directly.  Diabetes. 1997;  46 1235-1238
    CrossrefPubMedGoogle Scholar
  • 27 Lembo G, Vecchione C, Fratta L, Marino G, Trimarco V, d’Amati G, Trimarco B. Leptin induces direct vasodilatation through distinct endothelial mechanisms.  Diabetes. 2000;  49 293-297
    PubMedGoogle Scholar
  • 28 Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile M T, Fratta L, Trimarco V, Trimarco B, Lembo G. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.  Diabetes. 2002;  51 168-173
    PubMedGoogle Scholar
  • 29 Shek E W, Brands M W, Hall J E. Chronic leptin infusion increases arterial pressure.  Hypertension. 1998;  31 409-414
    CrossrefPubMedGoogle Scholar
  • 30 Carlyle M, Jones O B, Kuo J J, Hall J E. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity.  Hypertension. 2002;  39 496-501
    CrossrefPubMedGoogle Scholar
  • 31 Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity-related hypertension.  J Clin Invest. 2000;  105 1243-1252
    CrossrefPubMedGoogle Scholar
  • 32 Hall J E. Pathophysiology of obesity hypertension.  Curr Hypertens Rep. 2000;  2 139-147
    CrossrefPubMedGoogle Scholar
  • 33 Rocchini A P. Obesity hypertension, salt sensitivity and insulin resistance.  Nutr Metab Cardiovasc Dis. 2000;  10 287-294
    PubMedGoogle Scholar
  • 34 Cooper R, McFarlane-Anderson N, Bennet F I, Wilks R, Puras A, Tewksbury D, Ward R, Forrester T. ACE, angiotensinogen and obesity: a potential pathway leading to hypertension.  J Hum Hypertens. 1997;  11 107-111
    CrossrefPubMedGoogle Scholar
  • 35 Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients.  Am J Hypertens. 1997;  10 629-633
    CrossrefPubMedGoogle Scholar
  • 36 Licata G, Scaglione R, Ganguzza A, Corrao S, Donatelli M, Parrinello G, Dichiara M A, Merlino G, Cecala M G. Central obesity and hypertension: relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.  Am J Hypertens. 1994;  7 314-320
    CrossrefPubMedGoogle Scholar
  • 37 Egan B M, Stepniakowski K, Goodfriend T L. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.  Am J Hypertens. 1994;  7 886-893
    CrossrefPubMedGoogle Scholar
  • 38 Stowasser M, Gunasekera T G, Gordon R D. Familial varieties of primary aldosteronism.  Clin Exp Pharmacol Physiol. 2001;  28 1087-1090
    CrossrefPubMedGoogle Scholar
  • 39 Goodfriend T L, Egan B M, Kelley D E. Aldosterone in obesity.  Endocr Res. 1998;  24 789-796
    CrossrefPubMedGoogle Scholar
  • 40 Rocchini A P, Katch V L, Grekin R, Moorehead C, Anderson J. Role for aldosterone in blood pressure regulation of obese adolescents.  Am J Cardiol. 1986;  57 613-618
    CrossrefPubMedGoogle Scholar
  • 41 El Gharbawy A H, Nadig V S, Kotchen J M, Grim C E, Sagar K B, Kaldunski M, Hamet P, Pausova Z, Gaudet D, Gossard F. et al . Arterial pressure, left ventricular mass, and aldosterone in essential hypertension.  Hypertension. 2001;  37 845-850
    PubMedGoogle Scholar
  • 42 Goodfriend T L, Kelley D E, Goodpaster B H, Winters S J. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women.  Obes Res. 1999;  7 355-362
    CrossrefPubMedGoogle Scholar
  • 43 Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart.  Am J Med Sci. 2001;  321 242-248
    PubMedGoogle Scholar
  • 44 Paula R B, Silva A A, Hall J E. Aldosterone antagonism attenuates obesity-induces hypertension and glomerular hyperfiltration.  Hypertension. 2004;  43 1-7
    PubMedGoogle Scholar
  • 45 He J, Ogden L G, Bazzano L A, Vupputuri S, Loria C, Whelton P K. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.  Arch Intern Med. 2002;  162 1619-1624
    CrossrefPubMedGoogle Scholar
  • 46 He J, Ogden L G, Vupputuri S, Bazzano L A, Loria C, Whelton P K. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults.  JAMA. 1999;  282 2027-2034
    CrossrefPubMedGoogle Scholar
  • 47 Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients.  J Hypertens. 1997;  15 1695-1699
    CrossrefPubMedGoogle Scholar
  • 48 Goodfriend T L, Ball D L, Gardner H W. An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro.  Prostaglandins Leukot Essent Fatty Acids. 2002;  67 163-167
    CrossrefPubMedGoogle Scholar
  • 49 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg H S, Barthel A, Hauner H, McCann S M, Scherbaum W A, Bornstein S R. Human adipocytes secrete mineralocorticoid-releasing factors.  Proc Natl Acad Sci USA. 2003;  100 14 211-14 216
    PubMedGoogle Scholar
  • 50 Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc J M, Quignard-Boulangé A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.  FASEB. 2001;  15 2727-2729
    PubMedGoogle Scholar
  • 51 Frossard P M, Parvez S H, Lestringant G G, Kureshi N S. Associations between the human insulin gene 5′ VNTR and clinical variables of the renin-angiotensin system.  Neuroendocrinol Lett. 2003;  24 325-328
    PubMedGoogle Scholar
  • 52 Cooper R S, Gui X, Rotimi C N, Luke A, Ward R, Adeyemo A, Danilov S M. Heritability of angiotensin-converting enzyme and angiotensinogen. A comparison of US blacks and nigerians.  Hypertension. 2000;  35 1141-1147
    PubMedGoogle Scholar
  • 53 Kim S, Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte.  J Nutr. 2000;  13 3110S-3115S
    PubMedGoogle Scholar
  • 54 Trayhurn P, Beattie J H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.  Proc Nutr Soc. 2001;  60 329-339
    CrossrefPubMedGoogle Scholar
  • 55 Vrezas I, Wentworth P, Bornstein S R. Myelolipomatous foci on an adrenal adenoma causing Cushing’s syndrome.  Endocr Res. 2003;  29 67-71
    CrossrefPubMedGoogle Scholar

V. Lamounier-Zepter, M. D.

German Diabetes Center

Auf’m Hennekamp 65 · 40225 Düsseldorf · Germany

Phone: + 49 (211) 338 22 02

Fax: + 49 (211) 338 24 82 ·

Email: Valeria.LamounierZepter@uni-duesseldorf.de